Aegerion is dedicated to the development and commercialization of novel therapies for patients with debilitating, often fatal, rare diseases.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating often fatal, rare diseases.

5.31.2013 - Aegerion Pharmaceuticals Receives Positive European CHMP Opinion for LOJUXTA(tm) (lomitapide) to Treat Homozygous Familial Hypercholesterolemia (HoFH)
4.30.2013 - Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results
4.29.2013 - Anne VanLent Appointed to Aegerion Pharmaceuticals' Board of Directors

all news |

subscribe to feed

2012 Annual Report

Symbol: AEGR
Last Price: 62.950
Change: -0.750
Volume: 173100
Quote Date: 6/19/2013 12:27:31 PM